Welcome to our dedicated page for Freshpet SEC filings (Ticker: FRPT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Freshpet's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Freshpet's regulatory disclosures and financial reporting.
SCALZO JOSEPH reported acquisition or exercise transactions in this Form 4 filing.
Freshpet, Inc. director Joseph Scalzo received an award of 1,589 shares of restricted common stock as equity compensation. The grant was made at no cash cost per share and increases his direct holdings to 5,629 shares. These restricted shares vest on March 15, 2027, if he continues serving on the board through that date.
O'Connor John Gregory reported acquisition or exercise transactions in this Form 4 filing.
Freshpet, Inc. reported that Chief Financial Officer John Gregory O'Connor received a grant of 4,814 shares of Common Stock in the form of restricted stock units under the Freshpet, Inc. 2024 Equity Incentive Plan. These units vest in three equal annual installments beginning on March 15, 2027, subject to his continued service. Following this award, he holds 12,314 shares of Common Stock directly.
Kelley Jacki Sue reported acquisition or exercise transactions in this Form 4 filing.
Freshpet, Inc. director Jacki Sue Kelley reported receiving a grant of 1,589 shares of restricted Common Stock as equity compensation. The award was made at no cost and increased her direct holdings to 13,496 shares. These restricted shares vest on March 15, 2027, provided she continues to serve on Freshpet’s Board of Directors through that date.
WEST DAVID J reported acquisition or exercise transactions in this Form 4 filing.
Freshpet director David J. West received an equity award of 1,589 shares of restricted common stock. The grant was made under Freshpet’s 2024 Equity Incentive Plan at no cash cost to him and brings his direct holdings to 5,953 shares of common stock.
The restricted shares are scheduled to vest on March 15, 2027, provided West continues to serve on Freshpet’s Board of Directors through that date. This filing reflects routine director compensation in the form of long-term, stock-based incentives.
BREWSTER DARYL G reported acquisition or exercise transactions in this Form 4 filing.
Freshpet, Inc. director Daryl G. Brewster received an award of 1,589 shares of restricted common stock as equity compensation. The stock was granted at no cash cost and was issued under the company’s 2024 Equity Incentive Plan.
These restricted shares are scheduled to vest on March 15, 2027, provided Brewster continues serving on Freshpet’s Board of Directors through that date. After this grant, he directly holds a total of 59,334 shares of Freshpet common stock.
Biegger David reported acquisition or exercise transactions in this Form 4 filing.
Freshpet, Inc. director David Biegger received an award of 1,589 shares of restricted common stock, with no cash paid per share. The grant was made under the company’s 2024 Equity Incentive Plan and will vest on March 15, 2027, if he continues serving on the board. Following this award, he directly holds 7,488 common shares.
Walsh Cathal reported acquisition or exercise transactions in this Form 4 filing.
Freshpet, Inc. senior vice president and Managing Director, Europe, Cathal Walsh reported an equity award on Common Stock. He received 1,299 restricted stock units under the Freshpet, Inc. 2024 Equity Incentive Plan, increasing his direct holdings to 7,701 shares after the transaction.
The restricted stock units are scheduled to vest in three equal annual installments beginning on March 15, 2027. Vesting is contingent on Walsh’s continued service with the company, aligning his compensation with longer‑term performance and retention.
Steeneck Craig D. reported acquisition or exercise transactions in this Form 4 filing.
Freshpet, Inc. director Craig D. Steeneck received an award of 1,589 shares of restricted Common Stock as equity compensation. These shares were granted at no cash cost and increase his direct holdings to 35,500 shares. The restricted shares were issued under Freshpet's 2024 Equity Incentive Plan and are scheduled to vest on March 15, 2027, provided he continues serving on the Board of Directors through that date.
Baty Nicola J. reported acquisition or exercise transactions in this Form 4 filing.
Freshpet, Inc. reported that Chief Operating Officer Nicola J. Baty received an award of 5,382 shares of Common Stock in the form of restricted stock units under the Freshpet, Inc. 2024 Equity Incentive Plan. These units carry no purchase price and increase her direct holdings to 38,716 shares.
The restricted stock units are scheduled to vest in three equal annual installments beginning on March 15, 2027, and each installment is conditioned on her continued service with the company. This filing reflects a compensation-related equity grant rather than an open-market share purchase or sale.
Freshpet, Inc. director Walter N. George purchased 630 shares of common stock in an open-market transaction at a weighted average price of $79.04 per share on February 25, 2026. Following this purchase, he directly owns 47,157 Freshpet shares.